Pathward extends TabaPay partnership through 2031
Reuters2026/08/05 03:01- Pathward Financial extended its partnership with money movement platform TabaPay through 2031, expanding program offerings.
- Agreement adds lending disbursements, cross-border money movement, preferred account funding, targeting faster payments across new use cases.
- Collaboration supports rapid bi-directional flows via ACH, push-to-card, acquiring, covering loan funding, repayments, account transfers.
- Expanded routing adds PULSE Disbursements for push payments to Discover Network-branded cards, alongside Mastercard Move and Visa Direct.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations